4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001193125-26-037573
Director sold 15,000 shares at $10.72 ($160,857)
From the SEC's structured data for this filing
Trades in this filing
Gould Robert J · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Sale : show line 1 in the form | −15,000 | $10.72 | $160,857 | 454,864 | D |
| Open-market sales · 15,000 sh · avg $10.72 · $160,857 | ||||||
Loading xslF345X05/ownership.xml…